These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22822914)

  • 1. Discovery of novel antibacterials.
    Miller JR; Waldrop GL
    Expert Opin Drug Discov; 2010 Feb; 5(2):145-54. PubMed ID: 22822914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel agents to inhibit microbial virulence and pathogenicity.
    Escaich S
    Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance.
    Pokrovskaya V; Baasov T
    Expert Opin Drug Discov; 2010 Sep; 5(9):883-902. PubMed ID: 22823262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platforms for the identification of GPCR targets, and of orthosteric and allosteric modulators.
    Franco R; Canela EI; Casado V; Ferre S
    Expert Opin Drug Discov; 2010 Apr; 5(4):391-403. PubMed ID: 22823089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application.
    Al-Mahrous MM; Upton M
    Expert Opin Drug Discov; 2011 Feb; 6(2):155-70. PubMed ID: 22647134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and design of carbohydrate-based therapeutics.
    Cipolla L; Araújo AC; Bini D; Gabrielli L; Russo L; Shaikh N
    Expert Opin Drug Discov; 2010 Aug; 5(8):721-37. PubMed ID: 22827796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of conventional and alternative strategies for developing new antibacterial agents.
    Oancea S
    Acta Chim Slov; 2010 Sep; 57(3):630-42. PubMed ID: 24061811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of antibacterial discovery revisited.
    Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ
    Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare actinomycetes: a potential storehouse for novel antibiotics.
    Tiwari K; Gupta RK
    Crit Rev Biotechnol; 2012 Jun; 32(2):108-32. PubMed ID: 21619453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plants as sources of new antimicrobials and resistance-modifying agents.
    Abreu AC; McBain AJ; Simões M
    Nat Prod Rep; 2012 Sep; 29(9):1007-21. PubMed ID: 22786554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can high-throughput screening deliver drugs to treat atherosclerosis?
    Yang Y; Wang L; Si S; Hong B
    Expert Opin Drug Discov; 2010 Dec; 5(12):1175-88. PubMed ID: 22822720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-based apoptosis assays in oncology drug discovery.
    Drewe J; Cai SX
    Expert Opin Drug Discov; 2010 Jun; 5(6):583-96. PubMed ID: 22823169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing new antibacterials through natural product research.
    Kirst HA
    Expert Opin Drug Discov; 2013 May; 8(5):479-93. PubMed ID: 23480029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of SBDD to the discovery of new antibacterial drugs.
    Finn J
    Methods Mol Biol; 2012; 841():291-319. PubMed ID: 22222458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antibiotic resistome.
    Wright GD
    Expert Opin Drug Discov; 2010 Aug; 5(8):779-88. PubMed ID: 22827799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery.
    Campbell JW; Cronan JE
    Annu Rev Microbiol; 2001; 55():305-32. PubMed ID: 11544358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small and lethal: searching for new antibacterial compounds with novel modes of action.
    Pathania R; Brown ED
    Biochem Cell Biol; 2008 Apr; 86(2):111-5. PubMed ID: 18443624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Acinetobacter infections.
    Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current strategies for drug discovery through natural products.
    Harvey AL; Clark RL; Mackay SP; Johnston BF
    Expert Opin Drug Discov; 2010 Jun; 5(6):559-68. PubMed ID: 22823167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.